‘We Cannot Wait 75 Years’: ANRF Chief Pushes Patient Capital to Scale India’s Research Multiplier
ANRF CEO Shivkumar Kalyanaraman has outlined a patient-capital framework aimed at accelerating India’s research and development intensity toward 3% of GDP, arguing that the country cannot afford a slow, decades-long climb. The model combines private investment, open intellectual property licensing and national mission programmes to convert research into scalable innovation and commercial outcomes.
